Abstract
We previously reported that intrathecal pro-opiomelanocortin gene electroporation could reduce pain sensitivity induced by chronic constriction injury (CCI) of the sciatic nerve. For optimal use of antinociceptive gene therapy, it might be important to control the expression of the transfected gene extrinsically. For this purpose, a doxycycline-controlled transrepressor system composed of two plasmids coding, respectively, for pro-opiomelanocortin gene (pTRE2-POMC) and the silencer (pTel-off) was employed. The regulation of beta-endorphin expression was first assessed in spinal neuronal culture, then we electrotranfected this plasmid into the spinal cord of mononeuropathic rats and evaluated the analgesic potential of this therapy in vivo by thermal and mechanical withdrawal latency. Intraperitoneal injections of various doses of doxycycline were made to elucidate the possible exogenous downregulation of transfected beta-endorphin gene expression in vivo. The levels of beta-endorphin were analyzed by intrathecal microdialysis and radioimmunoassay. Intrathecal pTRE2-POMC/pTel-off electroporation elevated spinal beta-endorphin levels, as manifested in a significantly elevated pain threshold for chronic constriction injury limbs. Intraperitoneal doxycycline decreased the antinociceptive effect and spinal beta-endorphin levels in a dose-dependent manner. We concluded that intrathecal pTRE2-POMC/pTel-off electroporation alleviates CCI-induced limb pain, and can be controlled by intraperitoneal doxycycline administration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Oyama T et al. Profound analgesic effects of beta-endorphin in man. Lancet 1980; 1: 122–124.
Wen HL et al. Intrathecal administration of beta-endorphin and dynorphin-(1-13) for the treatment of intractable pain. Life Sci 1985; 37: 1213–1220.
Yaksh TL, Henry JL . Antinociceptive effects of intrathecally administered human beta-endorphin in the rat and cat. Can J Physiol Pharmacol 1978; 56: 754–759.
Yaksh TL, Gross KE, Li CC . Studies on the intrathecal effect of beta-endorphin in primate. Brain Res 1982; 241: 261–269.
Mack KJ, Killian A, Weyhenmeyer JA . Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord. Life Sci 1984; 34: 281–285.
Atweh SF, Kuhar MJ . Autoradiographic localization of opiatereceptors in rat brain. I. Spinal and lower medulla. Brain Res 1977; 124: 53–67.
Morris BJ, Herz A . Distinct distribution of opioid receptor typesin rat lumbar spinal cord. Naunyn-Schmiedebergs Arch Pharmacol 1987; 336: 240–243.
Kitahata LM, Collins JG . Spinal action of narcotic analgesics. Anesthesiology 1981; 54: 153–163.
Aimone LD, Yaksh TL . Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides 1989; 10: 1127–1131.
Go VL, Yaksh TL . Release of substance P from the cat spinal cord. J Physiol 1987; 391: 141–167.
Seybold VS, Elde RP . Receptor autoradiography in thoracic spinal cord: correlation of neurotransmitter binding sites with sympathoadrenal neurons. J Neurosci 1984; 4: 2533–2542.
Brazenor GA . Long term intrathecal administration of morphine: a comparison of bolus infection via reservoir with continuous infusion by implanted pump. Neurosurgery 1987; 21: 484–491.
Oyama T, Murakawa T, Baba S, Nagao H . Continuous vs bolus epidural morphine. Acta Anaesthesiol Scand (Suppl) 1987; 85: 77–79.
Penn RD, Paice JA . Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67: 182–186.
Richelson E . Spinal opiate administration for chronic pain: a major advance in therapy. Mayo Clin Proc 1981; 56: 523.
Hassenbusch SJ et al. Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 1990; 73: 405–409.
Lin CR et al. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Therapy 2002; 18: 1247–1253.
Finegold AA, Mannes AJ, Iadarola MJ . A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther 1999; 10: 1251–1257.
Lin CR et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317: 1–4.
Rubanyi GM . The future of human gene therapy. Mol Aspects Med 2001; 22: 113–142.
Weber W, Fussenegger M . Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering. J Biotechnol 2002; 98: 161–187.
Clackson T . Regulated gene expression systems. Gene Therapy 2000; 7: 120–125.
Baron U, Bujard H . Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401–421.
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547–5551.
Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766–1769.
Bohl D, Salvetti A, Moullier P, Heard JM . Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512–1517.
Saitoh Y et al. Analgesia induced by transplantation of encapsulated tumor cells secreting beta-endorphin. J Neurosurg 1995; 82: 630–634.
Saitoh Y et al. Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum Gene Ther 1998; 9: 997–1002.
Ishii K, Isono M, Inoue R, Hori S . Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation. Exp Neurol 2000; 166: 90–98.
Gehl J, Mir LM . Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261: 377–380.
Lan CY et al. Immunoneutralization of c-Fos using intrathecal antibody electroporation attenuates chronic constrictive injury-induced hyperalgesia and regulates preprodynorphin expression in rats. Anesthesiology 2003; 99: 938–946.
Teichler Zallen D . US gene therapy in crisis. Trends Genet 2000; 16: 272–275.
Osumi N, Inoue T . Gene transfer into cultured mammalian embryos by electroporation. Methods 2001; 24: 35–42.
Maruyama H et al. Skin-targeted gene transfer using in vivo electroporation. Gene Therapy 2001; 23: 1808–1812.
Lin CR et al. Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain. Cell Transplant 2002; 11: 17–24.
Lin CR et al. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats. Anesth Analg 2003; 96: 1711–1716.
Hargreaves K et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77–88.
Acknowledgements
This work was supported by Grant No. 92-2314-B-182A-149- to Chung-Ren Lin from the National Science Council, Taipei, Taiwan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, CM., Lin, MW., Cheng, JT. et al. Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats. Gene Ther 11, 933–940 (2004). https://doi.org/10.1038/sj.gt.3302244
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.gt.3302244
Keywords
This article is cited by
-
Recent Advances in Management of Neuropathic, Nociceptive, and Chronic Pain: A Narrative Review with Focus on Nanomedicine, Gene Therapy, Stem Cell Therapy, and Newer Therapeutic Options
Current Pain and Headache Reports (2024)
-
Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain
Scientific Reports (2016)
-
Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo
Cell Biology and Toxicology (2010)
-
Peripheral Non-Viral MIDGE Vector-Driven Delivery of β-Endorphin in Inflammatory Pain
Molecular Pain (2009)
-
Intrathecal Injection of Naked Plasmid DNA Provides Long-term Expression of Secreted Proteins
Molecular Therapy (2009)


